# North Carolina Newborn Exome Sequencing for Universal Screening

> **NCT02826694** · NA · COMPLETED · sponsor: **University of North Carolina, Chapel Hill** · enrollment: 106 (actual)

## Conditions studied

- Metabolism, Inborn Errors
- Hearing Loss
- Hereditary Disease

## Interventions

- **GENETIC:** Well infant, whole exome sequencing
- **GENETIC:** Diagnosed, whole exome sequencing

## Key facts

- **NCT ID:** NCT02826694
- **Lead sponsor:** University of North Carolina, Chapel Hill
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-06
- **Primary completion:** 2019-06-30
- **Final completion:** 2019-06-30
- **Target enrollment:** 106 (ACTUAL)
- **Last updated:** 2020-07-08

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02826694

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02826694, "North Carolina Newborn Exome Sequencing for Universal Screening". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02826694. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*